DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Gallamini A, Zaja F, Patti C. , et al.
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.
Blood 2007;
110 (07) 2316-2323
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.